CoChat

Depression in rheumatoid arthritis—underscoring the problem

Sheehy, C., Murphy, E., Barry, M. · 2006 · Rheumatology
Cited by 145

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The greatest mistake in the treatment of diseases is that there are physicians for the body and physicians for the soul, although the two cannot be separated. Plato (427–347 BC) The management of chronic disease is a major challenge for global health care in the 21st century. The World Health Organization estimates that by the year 2020, depressive disorders will be second only to ischaemic heart disease in the worldwide burden of disease [1]. Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disease, affecting 0.5–1% of the population. It has long been recognized that the two conditions are associated, with conservative estimates of the prevalence of depressive disorder in patients with RA ranging between 13 and 20% [2–4]. These estimates control for the overlap between the symptomatology of RA and depression. This is a higher prevalence than might be expected from clinical practice. However, recent data from the British Society for Rheumatology Biologics Register [5], looking at baseline comorbidity levels in over 7000 patients starting biological treatment, showed that 19% of these patients had been given a formal diagnosis of depression at one time. These rates are 2–3 times higher than for the general population. Studies have estimated that depressive disorder occurs in 2–4% of persons in the community and in 5–10% of primary care patients [6]. A diagnosis of RA given has physical, psychological and socio-economic implications for the individual. From a psychological point of view, people with RA fear long-term pain, stiffness and fatigue. Most dread the development of joint deformities, especially of the hands. They have concerns about loss of function, work disability and the possible socio-economic effects of the disease. The potential toxicity of long-term treatment with disease modifying agents is also a worry. Despite these rational fears and the major physical challenges that patients with RA face over many years, the majority do not develop depressive disorder. However, the significant proportion —perhaps as high as 1 in 5 to 1 in 10 out-patients—who do develop significant symptoms of depression carry a second heavy burden. Concomitant depression and RA disproportionately worsen many outcomes. Depression is linked with increased pain levels [3]. The causal relationship between pain and low mood most likely works in both directions [7, 8]. Comorbid depression has been shown to independently increase work disability in RA [9]. The loss of recreational and social activities in people with RA has been shown to significantly increase the risk of depressive symptoms [10]. The coexistence of both conditions adds to the burden of the disease on the health care system as well, with increased physician and general practitioner visits, increased pain complaints and more requests for analgesia. Depression can result in poor adherence to treatment. Depression has been demonstrated to be an independent risk factor for mortality (non-suicide) in patients with RA [11]. This study by Ang et al. [11], involving 1290 patients with RA, showed that the cohort with persistent or recurrent depression over an initial 4 yr period had higher mortality rates than those without depression, when followed up over the subsequent 18 yrs. Rates and patterns of suicide in patients with RA have also been studied. Timonen et al [12]. showed that 50% of their cohort of 19 patients with RA who had committed suicide were women, a much higher female percentage compared with the general population (18% in their study). About 90% of these women had suffered from comorbid depression. Treharne et al. [13] found that 11% of hospital out-patients with RA had suicidal ideation at one time; 30% of their patients with depression reported suicidal ideation. There has been much discussion in the literature regarding the factors that influence the development of depressive symptoms in patients with RA. Disease activity alone does not equate with depressive symptoms reliably; many people with high levels of pain and disability do not report symptoms of depression [4]. Factors that have been purported to be influential include female gender [14], younger age at diagnosis [14] and personality traits such as low self-esteem, helplessness and avoidant (employing denial) coping [8, 15, 16]. Individuals vary greatly in their psychosocial acceptance of the diagnosis of RA, and poor adjustment to this diagnosis contributes to the onset of depressive symptoms [17]. It is recognized that rates of depression may be at least as high for patients recently diagnosed as for those with chronic RA [18]. Groarke et al. [17] found that illness perception had a greater effect than disease activity on the variance of pain in RA. They found that patients who perceived that the disease would last indefinitely, would have serious consequences, with little chance of cure or control, adjusted less well both physically and psychologically. Along with

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/rheumatology/kel231

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 145

Metadata

Authors
Sheehy, C., Murphy, E., & Barry, M.
Venue
Rheumatology
Published
2006-08-14
Volume
45
Issue
11
Pages
1325-1327
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W2041769664
Cited by
145
References
2
FWCI
2.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Depression in rheumatoid arthritis—underscoring the problem. https://app.cochat.ai/papers/10.1093/rheumatology/kel231
The paper
Sheehy, C., Murphy, E., & Barry, M. (2006). Depression in rheumatoid arthritis—underscoring the problem. Rheumatology. https://doi.org/10.1093/rheumatology/kel231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.